A novel method in order to evaluate the efficacies and the safeties of new drugs for hepatocellular carcinoma with loss of transforming growth factor-beta signaling.

@article{Moriguchi2009ANM,
  title={A novel method in order to evaluate the efficacies and the safeties of new drugs for hepatocellular carcinoma with loss of transforming growth factor-beta signaling.},
  author={Hisashi Moriguchi},
  journal={Hepatology},
  year={2009},
  volume={50 6},
  pages={2050-1; author reply 2051}
}
sient elastography alone were 72.4% and 96.6%, respectively.1 Because the addition of FIB-4 could not significantly improve the performance of LSM to exclude advanced fibrosis, its major role is probably a confirmatory test for advanced fibrosis as suggested by transient elastography. If liver biopsy was performed in all patients with LSM 7.9 kPa, 98 (39.8… CONTINUE READING